AIM
AIM ImmunoTech
35 hedge funds and large institutions have $7.12M invested in AIM ImmunoTech in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$49K | |
| 2 | +$13.9K | |
| 3 | +$13.4K | |
| 4 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
+$1.57K |
| 5 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$1K |
Top Sellers
| 1 | -$294K | |
| 2 | -$232K | |
| 3 | -$58.4K | |
| 4 |
Morgan Stanley
New York
|
-$52.3K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$45K |